Clinical Study
Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients
Figure 4
Median OS patients in Tregs < 21/μL; Tregs ≥ 21/μL; poor and low-intermediate risk group, respectively (5, 18, 5, and 18 months; log-rank test; ).